Title of article :
The Emergence of Co-Infection of Visceral Leishmaniasis in an Iranian Child with Chronic Granulomatous Disease: A Case Report
Author/Authors :
ABDOLSALEHI, Mohammad Reza Department of Infectious Diseases - Pediatrics Center of Excellence - Children's Medical Center - Tehran University of Medical Sciences, Tehran, Iran , MOHEBALI, Mehdi Department of Parasitology and Mycology - School of Public Health - Tehran University of Medical Sciences, Tehran, Iran , KESHAVARZ, Hossein Department of Parasitology and Mycology - School of Public Health - Tehran University of Medical Sciences, Tehran, Iran , MAHMOUDI, Shima Pediatric Infectious Disease Research Center - Tehran University of Medical Sciences, Tehran, Iran , MAMISHI, Setareh Department of Infectious Diseases - Pediatrics Center of Excellence - Children's Medical Center - Tehran University of Medical Sciences, Tehran, Iran
Pages :
5
From page :
159
To page :
163
Abstract :
Chronic granulomatous disease (CGD) described as an essential immunodeficiency problem of phagocytic cells resulting in a phagocyte dysfunction and inability to kill a spectrum of bacteria and fungi. Despite the fact that CGD patients are more susceptible to intracellular infections, visceral leishmaniasis has been reported rarely in these cases. Here, we report an uncommon case of visceral leishmaniasis in a child with CGD. An 8-yr old boy with CGD presented to the infectious disease ward, Children's Medical Center, Tehran University of Medical Sciences, Iran after the onset of 20 days fever with chronic crusted ulcer approximately 3 cm × 3cm on the left upper limb and a small ulcer measuring 0.5 cm × 0.5 cm on the right knee with moderate secretion. Bone Marrow Aspiration (BMA) and Bone Marrow Biopsies (BMB) of fragmented samples were performed and polymorphic population of hematopoietic cells, Megakaryocytes and Leishman bodies were seen. The patient was treated with meglumine antimoniate (Glucantime®) 20 mg/kg for 28 days and after partial improvement patient discharged and continue the treatment at home. Amphotericin B lipid complex (Ambisome®) (3–5 mg/kg per dose once) was administered every 3 -4 weeks for 18 months as secondary prophylaxis that was well tolerated and effective.
Keywords :
Iran , Child , Visceral leishmaniasis , Chronic granulomatous disease
Journal title :
Iranian Journal of Parasitology (IJP)
Serial Year :
2021
Record number :
2701945
Link To Document :
بازگشت